Purpose of review To review treatment options for patients with both ongoing acute epistaxis and chronic recurring epistaxis. Recent findings While a common occurrence, epistaxis can successfully be treated with adequate first aid, without a medical provider in most cases. Despite its common nature, widespread knowledge of appropriate first aid is lacking. Recurrent episodes may require further testing depending on the severity. Although a minority of patients referred to specialists have significant underlying pathology, there is little guidance in the literature to help inform practitioners regarding which patients warrant referral. While treatment options for idiopathic pediatric recurrent epistaxis is not currently an active area of research, investigators are actively pursuing novel treatments for hereditary hemorrhagic telangiectasia and endoscopic surgery for juvenile nasal angiofibroma (two rare causes of recurrent epistaxis). Summary Epistaxis is a common problem in the pediatric population which can lead to patient and family distress. Knowledge of appropriate treatment pathways is lacking and an area for improvement. Epistaxis that persists despite conventional treatment, or epistaxis in the context of a family history of excessive bleeding or a personal history of other sources of recurrent bleeding, may warrant additional evaluation. Introduction Epistaxis in childhood is a very common
Current Treatment Options in Pediatrics – Springer Journals
Published: Apr 12, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera